Model
Edge
Jazz Pharmaceuticals
JAZZ
Filing Type
10-Q
Filing Date
8/2/2026
Updated
8/3/26, 2:08 PM
Copy Ref
Filing
10-Q
Earnings Release
Exhibits
10-Q
Q2
EX-10.1
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
EX-31.1
CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-31.2
CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-32.1
CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350